Hypnonorm

Zolpidem, the active ingredient in Hypnonorm, is a non‑benzodiazepine hypnotic presented as a tablet for oral use. It treats insomnia in adults by helping initiate and maintain sleep.

GNH USA supplies Hypnonorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Zolpidem is indicated for the treatment of insomnia, a sleep‑wake disorder.

- Insomnia: helps adults fall asleep faster and stay asleep through the night. - Sleep onset insomnia: reduces the time needed to achieve sleep after bedtime. - Sleep maintenance insomnia: decreases nighttime awakenings and improves overall sleep duration.

Common side effects are generally mild and transient.

Common Side Effects: - Drowsiness - Dizziness - Headache - Nausea - Dry mouth - Unpleasant taste

Serious or Rare Side Effects: - Complex sleep behaviors (e.g., sleepwalking, sleep‑driving) - Allergic reactions such as rash or angioedema - Mood changes including depression or suicidal thoughts - Hallucinations or psychotic episodes - Respiratory depression, especially when combined with other CNS depressants - Anaphylaxis (rare)

Before prescribing Hypnonorm, clinicians should evaluate the patient’s sleep disorder and overall health status.

- Assess sleep pattern: confirm diagnosis of insomnia before initiating therapy. - Avoid CNS depressants: do not combine with alcohol, opioids, or other sedatives. - Use lowest effective dose: start with the minimal dose required for therapeutic effect. - Monitor for complex sleep behaviors: educate patients about unusual activities during sleep. - Caution in hepatic impairment: dose adjustment may be needed. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Zolpidem may interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Alcohol: additive sedation and increased risk of respiratory depression. - Opioids: heightened central nervous system depression. - Benzodiazepines or barbiturates: excessive sedation and impaired psychomotor function. - Rifampin: induces metabolism, reducing zolpidem plasma levels. - MAO inhibitors: may amplify hypnotic effects.

Moderate Interactions (Monitor Closely): - SSRIs (e.g., fluoxetine, sertraline): increased risk of abnormal sleep behaviors. - Antihistamines: additive drowsiness. - CYP3A4 inhibitors (e.g., ketoconazole): may raise zolpidem concentrations, requiring dose review.